Literature DB >> 10221884

Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline.

L A Jackson1, N L Smith, S R Heckbert, J T Grayston, D S Siscovick, B M Psaty.   

Abstract

To evaluate the association of prior treatment with antibiotics active against Chlamydia pneumoniae with the risk for incident myocardial infarction, we conducted a population-based case-control study. We found that use of erythromycin, tetracycline, or doxycycline during the previous 5 years was not associated with risk for first myocardial infarction. These results suggest little or no association between the use of these antibiotics and the risk for first myocardial infarction in the primary prevention setting.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221884      PMCID: PMC2640692          DOI: 10.3201/eid0502.990216

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  7 in total

1.  Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.

Authors:  E Gurfinkel; G Bozovich; A Daroca; E Beck; B Mautner
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

2.  Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen.

Authors:  L A Jackson; L A Campbell; C C Kuo; D I Rodriguez; A Lee; J T Grayston
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Alternative hypothesis for efficacy of macrolides in acute coronary syndromes.

Authors:  D Martin; J Bursill; M R Qui; S N Breit; T Campbell
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

4.  Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Authors:  S Gupta; E W Leatham; D Carrington; M A Mendall; J C Kaski; A J Camm
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

5.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

6.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

7.  The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

Authors:  B M Psaty; S R Heckbert; D Atkins; R Lemaitre; T D Koepsell; P W Wahl; D S Siscovick; E H Wagner
Journal:  Arch Intern Med       Date:  1994-06-27
  7 in total
  8 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

Review 3.  Chronic infections and atherosclerosis/thrombosis.

Authors:  Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

4.  Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.

Authors:  N J Wald; M R Law; J K Morris; X Zhou; Y Wong; M E Ward
Journal:  BMJ       Date:  2000-07-22

5.  Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction.

Authors:  Lars Bjerrum; Morten Andersen; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2005-12-06       Impact factor: 2.953

Review 6.  Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Authors:  I W Fong
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

7.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 8.  Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.

Authors:  Angel Y S Wong; Esther W Chan; Shweta Anand; Alan J Worsley; Ian C K Wong
Journal:  Drug Saf       Date:  2017-08       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.